Kyriacos A Athanasiou

Houston, TX, United States of America

Kyriacos A Athanasiou

This inventor holds 19 USPTO granted patents and 6 published patent applications and 1 EPO patent, primarily in Tissue Engineering. Top assignees: The University of Texas System, Salix Medical, Inc., University of California. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyriacos A Athanasiou. Retrieved from https://idiyas.com/inventor/kyriacos-a-athanasiou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 84.2

 

Average Co-Inventor Count = 2.7

ph-index = 15

Forward Citations = 4,001(Granted Patents)


Location History:

  • Helotes, TX (US) (1995 - 1997)
  • San Antonio, TX (US) (1996 - 2007)
  • Houston, TX (US) (2004 - 2014)
  • Irvine, CA (US) (2023)

Company Filing History:


Years Active: 1995-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Tissue Defects
Bioactive Agents
Health Monitoring
Biodegradable Implants
Stent Deployment
Temperature Monitoring
Cell Conservation
Cartilage Evaluator
Permeable Compositions
Variable Permeability
Multi-Phase Carriers
Surface Porosity
19 patents (USPTO):Explore Patents

Title: Inventor Kyriacos A Athanasiou: Pioneering Innovations in Tissue Engineering and Stent Technology

Introduction

Kyriacos A Athanasiou is a distinguished inventor based in Houston, Texas, known for his groundbreaking contributions to the fields of tissue engineering and stent technology. With a remarkable portfolio showcasing 17 patents, Athanasiou's work emphasizes the intersection of biology and engineering, leading to innovations that enhance medical treatments and procedures.

Latest Patents

Athanasiou's latest patents reflect his expertise and commitment to advancing medical technology. One of his significant patents is focused on "Dermis-derived cells for tissue engineering applications." This patent outlines methods for inducing differentiation of dermis-derived cells to serve as a source of chondrocytes, which are essential for forming tissue-engineered constructs. Notably, one method involves providing aggrecan-sensitive isolated dermis cells and seeding them onto an aggrecan-coated surface to foster the desired cellular differentiation.

Another notable patent from Athanasiou deals with "Method and apparatus for stent deployment with enhanced delivery of bioactive agents." This innovative stent design incorporates unprotected and protected regions. The protected regions contain bioactive agents, while the unprotected sections safeguard these agents when the stent is in its undeployed state. Once deployed, these bioactive agents contact the tissue or interior of a blood vessel directly, enhancing therapeutic delivery during medical procedures.

Career Highlights

Throughout his career, Athanasiou has been affiliated with several prestigious organizations, including the Massachusetts Institute of Technology (MIT) and Salix Medical, Inc. His work in these renowned institutions has further cultivated his reputation as a leading innovator in his field.

Collaborations

Kyriacos A Athanasiou has collaborated with esteemed colleagues, including George P Constantinides and Dan R Lanctot. These collaborations have enabled a rich exchange of ideas and fostered advancements within the realms of medical device innovation and tissue engineering.

Conclusion

Kyriacos A Athanasiou's contributions to the medical field through his numerous patents underline his role as a visionary inventor. His work not only pushes boundaries in tissue engineering but also significantly enhances the effectiveness of medical devices such as stents. As he continues to innovate, the impact of his inventions will undoubtedly influence the future of medical science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…